121 related articles for article (PubMed ID: 36496283)
1. Reduced risk of serious pneumococcal infections up to 10 years after a dose of pneumococcal conjugate vaccine in established arthritis.
Nagel J; Jönsson G; Nilsson JÅ; Manuswin C; Englund M; Saxne T; Kapetanovic MC
Vaccine; 2023 Jan; 41(2):504-510. PubMed ID: 36496283
[TBL] [Abstract][Full Text] [Related]
2. The risk of pneumococcal infections after immunization with pneumococcal conjugate vaccine compared to non-vaccinated inflammatory arthritis patients.
Nagel J; Geborek P; Saxne T; Jönsson G; Englund M; Petersson IF; Nilsson JÅ; Kapetanovic MC
Scand J Rheumatol; 2015; 44(4):271-9. PubMed ID: 25656734
[TBL] [Abstract][Full Text] [Related]
3. The association between antibody levels before and after 7-valent pneumococcal conjugate vaccine immunization and subsequent pneumococcal infection in chronic arthritis patients.
Nagel J; Geborek P; Saxne T; Jönsson G; Englund M; Petersson IF; Nilsson JÅ; Truedsson L; Kapetanovic MC
Arthritis Res Ther; 2015 May; 17(1):124. PubMed ID: 25986458
[TBL] [Abstract][Full Text] [Related]
4. Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors.
Kapetanovic MC; Roseman C; Jönsson G; Truedsson L; Saxne T; Geborek P
Arthritis Rheum; 2011 Dec; 63(12):3723-32. PubMed ID: 21834061
[TBL] [Abstract][Full Text] [Related]
5. Rituximab and abatacept but not tocilizumab impair antibody response to pneumococcal conjugate vaccine in patients with rheumatoid arthritis.
Crnkic Kapetanovic M; Saxne T; Jönsson G; Truedsson L; Geborek P
Arthritis Res Ther; 2013 Oct; 15(5):R171. PubMed ID: 24286269
[TBL] [Abstract][Full Text] [Related]
6. Heptavalent pneumococcal conjugate vaccine elicits similar antibody response as standard 23-valent polysaccharide vaccine in adult patients with RA treated with immunomodulating drugs.
Kapetanovic MC; Roseman C; Jönsson G; Truedsson L
Clin Rheumatol; 2011 Dec; 30(12):1555-61. PubMed ID: 21956234
[TBL] [Abstract][Full Text] [Related]
7. Persistence of antibody response 1.5 years after vaccination using 7-valent pneumococcal conjugate vaccine in patients with arthritis treated with different antirheumatic drugs.
Crnkic Kapetanovic M; Saxne T; Truedsson L; Geborek P
Arthritis Res Ther; 2013 Jan; 15(1):R1. PubMed ID: 23286772
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine.
Kapetanovic MC; Nagel J; Nordström I; Saxne T; Geborek P; Rudin A
Vaccine; 2017 Feb; 35(6):903-908. PubMed ID: 28081972
[TBL] [Abstract][Full Text] [Related]
9. Pneumococcal conjugate vaccines for preventing acute otitis media in children.
de Sévaux JL; Venekamp RP; Lutje V; Hak E; Schilder AG; Sanders EA; Damoiseaux RA
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD001480. PubMed ID: 33231293
[TBL] [Abstract][Full Text] [Related]
10. Initial Serological Response after Prime-boost Pneumococcal Vaccination in Rheumatoid Arthritis Patients: Results of a Randomized Controlled Trial.
Nguyen MTT; Lindegaard H; Hendricks O; Jørgensen CS; Kantsø B; Friis-Møller N
J Rheumatol; 2017 Dec; 44(12):1794-1803. PubMed ID: 28966211
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the immunogenicity of the 13-valent conjugated pneumococcal vaccine in rheumatoid arthritis patients treated with etanercept.
Rákóczi É; Perge B; Végh E; Csomor P; Pusztai A; Szamosi S; Bodnár N; Szántó S; Szücs G; Szekanecz Z
Joint Bone Spine; 2016 Dec; 83(6):675-679. PubMed ID: 26995488
[TBL] [Abstract][Full Text] [Related]
12. Pneumococcal conjugate vaccines for preventing acute otitis media in children.
Fortanier AC; Venekamp RP; Boonacker CW; Hak E; Schilder AG; Sanders EA; Damoiseaux RA
Cochrane Database Syst Rev; 2019 May; 5(5):CD001480. PubMed ID: 31135969
[TBL] [Abstract][Full Text] [Related]
13. A Systematic Review and Metaanalysis of Antirheumatic Drugs and Vaccine Immunogenicity in Rheumatoid Arthritis.
Subesinghe S; Bechman K; Rutherford AI; Goldblatt D; Galloway JB
J Rheumatol; 2018 Jun; 45(6):733-744. PubMed ID: 29545454
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with influenza and pneumococcal vaccine uptake among rheumatoid arthritis patients in Denmark invited to participate in a pneumococcal vaccine trial (Immunovax_RA).
Nguyen M; Lindegaard H; Hendricks O; Friis-Møller N
Scand J Rheumatol; 2017 Nov; 46(6):446-453. PubMed ID: 28145151
[TBL] [Abstract][Full Text] [Related]
15. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.
Kapetanovic MC; Saxne T; Sjöholm A; Truedsson L; Jönsson G; Geborek P
Rheumatology (Oxford); 2006 Jan; 45(1):106-11. PubMed ID: 16287919
[TBL] [Abstract][Full Text] [Related]
16. Prime-boost vaccination strategy enhances immunogenicity compared to single pneumococcal conjugate vaccination in patients receiving conventional DMARDs, to some extent in abatacept but not in rituximab-treated patients.
Nived P; Jönsson G; Settergren B; Einarsson J; Olofsson T; Jørgensen CS; Skattum L; Kapetanovic MC
Arthritis Res Ther; 2020 Feb; 22(1):36. PubMed ID: 32087733
[TBL] [Abstract][Full Text] [Related]
17. Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.
Kapetanovic MC; Kristensen LE; Saxne T; Aktas T; Mörner A; Geborek P
Arthritis Res Ther; 2014 Jan; 16(1):R2. PubMed ID: 24383620
[TBL] [Abstract][Full Text] [Related]
18. Influenza and Pneumococcal Vaccination Uptake in Patients with Rheumatoid Arthritis Treated with Immunosuppressive Therapy in the UK: A Retrospective Cohort Study Using Data from the Clinical Practice Research Datalink.
Costello R; Winthrop KL; Pye SR; Brown B; Dixon WG
PLoS One; 2016; 11(4):e0153848. PubMed ID: 27096429
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and persistence of a prime-boost re-vaccination strategy for pneumococcal vaccines in patients with rheumatoid arthritis.
Bahuaud M; Beaudouin-Bazire C; Husson M; Molto A; Launay O; Batteux F; Dougados M
Hum Vaccin Immunother; 2018 Jun; 14(6):1464-1470. PubMed ID: 29432051
[TBL] [Abstract][Full Text] [Related]
20. The effect of smoking and alcohol consumption on markers of systemic inflammation, immunoglobulin levels and immune response following pneumococcal vaccination in patients with arthritis.
Roseman C; Truedsson L; Kapetanovic MC
Arthritis Res Ther; 2012 Jul; 14(4):R170. PubMed ID: 22824238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
